Sereda E V, Gusel' V A, Feshchenko Iu I, Ustinovich A K, Zubovich V K, Trofimov V I, Nedostup A V, Ovchinnikov Iu M, Pluzhnikov M S, Darenkov A F
Antibiot Khimioter. 1993 Jun;38(6):45-50.
Multicentre trials of cefixime (Cefspan, Fujisawa Pharmaceutical Co., Ltd., Japan) were performed in 1992. The trials involved 137 children and 269 adult patients with inflammatory infections of the respiratory organs and urinary tracts and otorhinolaryngologic affections. Positive clinical and bacteriological results of the trials were stated in 76-90 per cent of the cases. The adverse reactions such as skin eruption and dyspepsia were rare and did not require the specific treatment.
